Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer
Triple negative breast cancer (TNBC) does not respond to checkpoint blockade
immunotherapy as a result of immunosuppressive tumor microenvironment. To remodel the …
immunotherapy as a result of immunosuppressive tumor microenvironment. To remodel the …
Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer
Y Liu, N Qiu, L Shen, Q Liu, J Zhang… - Journal of Controlled …, 2020 - cdr.lib.unc.edu
Triple negative breast cancer (TNBC) does not respond to checkpoint blockade
immunotherapy as a result of immunosuppressive tumor microenvironment. To remodel the …
immunotherapy as a result of immunosuppressive tumor microenvironment. To remodel the …
[引用][C] Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer
Y Liu, N Qiu, L Shen, Q Liu, J Zhang… - Journal of Controlled …, 2020 - cir.nii.ac.jp
Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer
Y Liu, N Qiu, L Shen, Q Liu, J Zhang… - … : official journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Triple negative breast cancer (TNBC) does not respond to checkpoint blockade
immunotherapy as a result of immunosuppressive tumor microenvironment. To remodel the …
immunotherapy as a result of immunosuppressive tumor microenvironment. To remodel the …
Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer.
Y Liu, N Qiu, L Shen, Q Liu, J Zhang… - Journal of Controlled …, 2020 - europepmc.org
Triple negative breast cancer (TNBC) does not respond to checkpoint blockade
immunotherapy as a result of immunosuppressive tumor microenvironment. To remodel the …
immunotherapy as a result of immunosuppressive tumor microenvironment. To remodel the …
[HTML][HTML] Nanocarrier-Mediated Immunogenic Chemotherapy for Triple Negative Breast Cancer
Y Liu, N Qiu, L Shen, Q Liu, J Zhang… - Journal of controlled …, 2020 - ncbi.nlm.nih.gov
Triple negative breast cancer (TNBC) does not respond to checkpoint blockade
immunotherapy as a result of immunosuppressive tumor microenvironment. To remodel the …
immunotherapy as a result of immunosuppressive tumor microenvironment. To remodel the …